Cesar Cardona is a Nephrology physician affiliated with Meharry Medical College. OpenAlex indexes 9 publications with 518 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
854 W. James Campbell Blvd.
Ste. 101a
Columbia, TN 38401
Telephone
931-388-3209Provider last certified this registry record 30 Oct 2025.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20258 payments
- Novo Nordisk IncProgram year20256 payments
- Travere Therapeutics, Inc.Program year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
62.2%Loop diuretic21.1%Furosemide84%Torsemide16%Part D≥190 patientsBeta blocker9.2%Bisoprolol Fumarate53%Carvedilol38%Metoprolol Tartrate10%Part D<11 patients+ 14 more classes in this area
Musculoskeletal
15.5%Xanthine oxidase inhibitor15.5%Allopurinol100%Part D≥137 patientsMetabolism & gastrointestinal
12.7%SGLT2 inhibitor5.1%Jardiance79%Farxiga21%Part D<11 patientsVitamin D3 Analog3.2%Calcitriol100%Part D≥26 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Spectrum of Kidney Diseases in Patients With Hepatitis C Virus Infection
American Journal of Clinical Pathology
2020 - Reliability and Utility of the Surprise Question in CKD Stages 4 to 5
American Journal of Kidney Diseases
2017 - Nephrology Provider Prognostic Perceptions and Care Delivered to Older Adults with Advanced Kidney Disease
Clinical Journal of the American Society of Nephrology
2017 - Dental management in the patient with hypertension: challenges and solutions
Clinical Cosmetic and Investigational Dentistry
2016 - Glycated Albumin and Risk of Death and Hospitalizations in Diabetic Dialysis Patients
Clinical Journal of the American Society of Nephrology
2011
Similar KOLs
Other experts from the same institution or the same specialty.
Benedict Maliakkal, MD
Meharry Medical College
Alfred Callahan, MD
Meharry Medical College
Ravi Gandhi, MD
Meharry Medical College
Thelma Hurd, MD
Meharry Medical College
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”